Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Cited by (1,001)

Items 101–200 of 1,001

1. From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
   Whitney L. Petrilli, Gregory C. Adam, Roman S. Erdmann, Pravien D. Abeywickrema, Vijayalakshmi Agnani, Xi Ai, Jennifer Baysarowich, Noel J. Byrne, John P. Caldwell, Wonsuk Chang et al. · 2019 · Cell chemical biology
2. Analysis of interactions between proteins and small-molecule drugs by a biosensor based on a graphene field-effect transistor
   Shicai Xu, Tie-Jun Wang, Guofeng Liu, Zanxia Cao, Ludmila Alekseevna Frank, Shouzhen Jiang, Chao Zhang, Zhenhua Li, Vasilisa Valerievna Krasitskaya, Qiang Li et al. · 2020 · Sensors and Actuators B Chemical
3. Directing evolution: the next revolution in drug discovery?
   Andrew M. Davis, Alleyn T. Plowright, Eric Valeur · 2017 · Nature Reviews Drug Discovery
4. Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer
   Marković, Iva, Savvides, Savvas N. · 2020 · Frontiers in Immunology
5. Antibody-based cancer therapy
   Rebecca S. Goydel, Christoph M. Rader · 2021 · Oncogene
6. Antiproliferative and Antimigratory Effects of a Novel YAP–TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
   Sarah Ann Smith, Richard Barry Sessions, Deborah K. Shoemark, Christopher Williams, Reza Ebrahimighaei, Madeleine C. McNeill, Matthew P. Crump, Tristan R. McKay, Gemma Harris, Andrew C. Newby et al. · 2019 · Journal of Medicinal Chemistry
7. Activity-Based DNA-Encoded Library Screening
   Wesley G. Cochrane, Marie L. Malone, Vuong Q. Dang, Valerie J. Cavett, Alexander Lee Satz, Brian M. Paegel · 2019 · ACS Combinatorial Science
8. A genetically encoded photoproximity labeling approach for mapping protein territories
   Nir Hananya, Xuanjia Ye, Shany Koren, Tom W. Muir · 2023 · Proceedings of the National Academy of Sciences
9. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
   Jara Kerstin Brenke, Grzegorz M. Popowicz, Kenji Schorpp, Ina Rothenaigner, Manfred Roesner, Isabel Meininger, Cédric Kalinski, Larissa Ringelstetter, Omar R'kyek, Gerrit Jürjens et al. · 2018 · Journal of Biological Chemistry
10. Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
    Yi Mou, Shuai Wen, Yuxiu Li, Xinxing Gao, Xin Zhang, Zhengyu Jiang · 2020 · European Journal of Medicinal Chemistry
11. Toward Small-Molecule Inhibition of Protein–Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions
    Damir Bojadzic, Péter Buchwald · 2018 · Current Topics in Medicinal Chemistry
12. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
    Minhong Shen, Yong Wei, Hahn Kim, Liling Wan, Yi‐Zhou Jiang, Xiang Hang, Michael Raba, Stacy Remiszewski, Michelle Rowicki, Cheng-Guo Wu et al. · 2021 · Nature Cancer
13. Artificial intelligence facilitates drug design in the big data era
    Wang, Liangliang, Ding, Junjie, Pan, Li, Cao, Dongsheng, Jiang, Hui, Ding, Xiaoqin · 2019 · Chemometrics and Intelligent Laboratory Systems
14. Targeting receptor complexes: a new dimension in drug discovery
    Mette Ishoey, Louise S. Clemmensen, David S. Bredt, Bernhard Bettler, Kristian Strømgaard · 2020 · Nature Reviews Drug Discovery
15. Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
    William McCoull, Roman Abrams, Erica K. Anderson, Kevin Blades, Peter Barton, Matthew R. Box, Jonathan Burgess, Kate F. Byth, Qing Cao, Claudio E. Chuaqui et al. · 2017 · Journal of Medicinal Chemistry
16. Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances
    Huanling Wu, Leonard Jeffrey Medeiros, Ken H. Young · 2017 · Blood Reviews
17. Polymerases of paramyxoviruses and pneumoviruses
    Rachel Fearns, Richard Karl Plemper · 2017 · Virus Research
18. Predicting Biomolecular Binding Kinetics: A Review
    Jinan Wang, Hung Nguyen Do, Kushal Koirala, Yinglong Miao · 2023 · Journal of Chemical Theory and Computation
19. Small molecules as inhibitors of PCSK9: Current status and future challenges
    Xu, Shengtao, Luo, Shanshan, Zhu, Zheying, Xu, Jinyi · 2019 · European Journal of Medicinal Chemistry
20. Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities
    T. Kruse, Carolin Benz, D. Garvanska, Richard Lindqvist, F. Mihalič, F. Coscia, Raviteja Inturi, A. Sayadi, L. Simonetti, E. Nilsson et al. · 2021 · Nature Communications
21. Donor–Acceptor Pyridinium Salts for Photo-Induced Electron-Transfer-Driven Modification of Tryptophan in Peptides, Proteins, and Proteomes Using Visible Light
    Caleb Hoopes, Francisco J. Garcia, Akash M. Sarkar, Nicholas J. Kuehl, David T. Barkan, Nicole Collins, Glenna E. Meister, Taylor R. Bramhall, Chien-Hsiang Hsu, Michael D. Jones et al. · 2022 · Journal of the American Chemical Society
22. Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective
    Julie M. Rainard, George C. Pandarakalam, Stuart P. McElroy · 2018 · SLAS DISCOVERY
23. Photocatalytic Activation of Aryl(trifluoromethyl) Diazos to Carbenes for High-Resolution Protein Labeling with Red Light
    David C. Cabanero, Stavros K. Kariofillis, Andrew C. Johns, Jinwoo Kim, Jizhi Ni, Sang‐Ho Park, Dann L. Parker, Carlo P. Ramil, Xavier Roy, Neel H. Shah et al. · 2024 · Journal of the American Chemical Society
24. PI3K: A Crucial Piece in the RAS Signaling Puzzle
    Agata Adelajda Krygowska, Esther Castellano · 2017 · Cold Spring Harbor Perspectives in Medicine
25. Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
    Sijbesma, Eline, Visser, Emira, Plitzko, Kathrin, Thiel, Philipp, Milroy, Lech-Gustav, Kaiser, Markus, Brunsveld, Luc, Ottmann, Christian · 2020 · Nature Communications
26. Fragment‐Based Stabilizers of Protein–Protein Interactions through Imine‐Based Tethering
    M. Wolter, Dario Valenti, Peter J. Cossar, Laura M. Levy, Stanimira Hristeva, Thorsten Genski, Torsten Hoffmann, Luc Brunsveld, Dimitrios Tzalis, Christian Ottmann · 2020 · Angewandte Chemie International Edition
27. Exploring Protein-Peptide Recognition Pathways Using a Supervised Molecular Dynamics Approach
    Veronica Salmaso, Mattia Sturlese, Alberto Cuzzolin, Stefano Moro · 2017 · Structure
28. Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
    F. Niu, Jin Yan, Bohan Ma, Shichao Li, Yongping Shao, Pengcheng He, Wanggang Zhang, Wangxiao He, Peter X. Ma, Wuyuan Lu · 2018 · Biomaterials
29. Computer-Aided Drug Design in Epigenetics
    Wenchao Lu, Rukang Zhang, Hao Jiang, Huimin Zhang, Cheng Luo · 2018 · Frontiers in Chemistry
30. Computer-Aided Ligand Discovery for Estrogen Receptor Alpha
    Divya Bafna, Fuqiang Ban, Paul S. Rennie, Kriti Singh, Artem R Cherkasov · 2020 · International Journal of Molecular Sciences
31. Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines
    Chiara Rinoldi, Seyed Shahrooz Zargarian, Paweł Nakielski, Xiaoran Li, Anna Liguori, Francesca Petronella, Dario Presutti, Qiusheng Wang, Marco Costantini, Luciano De Sio et al. · 2021 · Small Methods
32. In situ identification of cellular drug targets in mammalian tissue
    Zhengyuan Pang, Michael A. Schafroth, Daisuke Ogasawara, Yu Wang, Victoria Nudell, Neeraj K. Lal, Dong Uk Yang, Kristina Wang, Dylan M. Herbst, Jacquelyn Ha et al. · 2022 · Cell
33. An overview of DNA-encoded libraries: A versatile tool for drug discovery
    Daniel Hargbøll Madsen, Carlos Azevedo, Iolanda Micco, Lars Kolster Petersen, Nils Jakob Vest Hansen · 2020 · Progress in medicinal chemistry
34. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review
    Neetu Tripathi, Manoj Kumar Goshisht, Sanat Kumar Sahu, Charu Arora · 2021 · Molecular Diversity
35. An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings
    Irene Maffucci, Xiao Hu, Valentina Fumagalli, Alessandro Contini · 2018 · Frontiers in Chemistry
36. Computer-Aided Drug Discovery for Undruggable Targets
    Qi Sun, Hanping Wang, Juan Xie, Liying Wang, Junxi Mu, Junren Li, Yuhao Ren, Luhua Lai · 2025 · Chemical Reviews
37. A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery
    Shaogeng Tang, Peter S. Kim · 2019 · Proceedings of the National Academy of Sciences
38. Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
    Dane Huang, Chao Zhao, Ruyue Li, Bingyi Chen, Yuting Zhang, Zhejun Sun, Junkang Wei, Huihao Zhou, Qiong Gu, Jun Xu · 2022 · Nature Communications
39. DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
    Hu, Jing, Gao, Jie, Fang, Xiaomin, Liu, Zijing, Wang, Fan, Huang, Weili, Wu, Hua, Zhao, Guodong · 2022 · Briefings in Bioinformatics
40. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning
    Bell, Eric W., Schwartz, Jacob H., Freddolino, Lydia, Zhang, Yang · 2022 · Journal of Molecular Biology
41. Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling
    Mathias Wendt, Rosa Bellavita, Alan Gerber, Nina‐Louisa Efrém, Thirza van Ramshorst, Nicholas M. Pearce, Paul R. J. Davey, Isabel Everard, Mercedes Vázquez–Chantada, Elisabetta Chiarparin et al. · 2021 · Angewandte Chemie International Edition
42. Mapping, Structure and Modulation of PPI
    Elisa Martino, S. Chiarugi, F. Margheriti, G. Garau · 2021 · Frontiers in Chemistry
43. Catalytic Metallodrugs: Substrate‐Selective Metal Catalysts as Therapeutics
    Zhen Yu, James Allan Cowan · 2017 · Chemistry - A European Journal
44. The era of high-quality chemical probes
    Marco P. Licciardello, Paul Workman · 2022 · RSC Medicinal Chemistry
45. Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer Therapy
    Yazhen Wang, Yang Zhou, Lianyi Yang, Lei Lei, Bin He, Jun Cao, Huile Gao · 2023 · Advanced Science
46. Therapeutic design of peptide modulators of protein-protein interactions in membranes
    Tracy A. Stone, Charles M. Deber · 2016 · Biochimica et Biophysica Acta (BBA) - Biomembranes
47. Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
    Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, Ge‐Fei Hao, Guang‐Fu Yang · 2023 · Trends in Biochemical Sciences
48. Supramolecular Senolytics via Intracellular Oligomerization of Peptides in Response to Elevated Reactive Oxygen Species Levels in Aging Cells
    Sangpil Kim, Jae‐Byoung Chae, Dohyun Kim, Chulwoo Park, Youjung Sim, Hyungwoo Lee, Gaeun Park, Jae-Eun Lee, Seong‐Ho Hong, Batakrishna Jana et al. · 2023 · Journal of the American Chemical Society
49. Recent Advances and Perspectives in Cancer Drug Design
    Luma G. Magalhães, Leonardo L. G. Ferreira, Adriano Defini Andricopulo · 2018 · Anais da Academia Brasileira de Ciências
50. Targeting VEGF–neuropilin interactions: a promising antitumor strategy
    Kewen Peng, Ying Bai, Qihua Zhu, Bin Hu, Yungen Xu · 2018 · Drug Discovery Today
51. A Thermodynamic Model for Multivalency in 14-3-3 Protein–Protein Interactions
    Loes M. Stevers, Pim J. de Vink, Christian Ottmann, Jurriaan Huskens, Luc Brunsveld · 2018 · Journal of the American Chemical Society
52. Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy
    Zonghui Ma, Ji Hoon Yu, Yifan Yu, Dailin Liang · 2021 · European Journal of Medicinal Chemistry
53. A Brief Overview of Two Major Strategies in Diversity-Oriented Synthesis: Build/Couple/Pair and Ring-Distortion
    Sihyeong Yi, Begur Vasanthkumar Varun, Yoona Choi, Seung Bum Park · 2018 · Frontiers in Chemistry
54. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane
    Akira Mizuno, Kouhei Matsui, Satoshi Shuto · 2017 · Chemistry - A European Journal
55. Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology
    Chayma El Khamlichi, Flora Reverchon, Nadège Hervouet, L. Blot, Éric Reiter, Séverine Morisset‐Lopez · 2019 · Molecules
56. Protein–Protein Interaction-Gaussian Accelerated Molecular Dynamics (PPI-GaMD): Characterization of Protein Binding Thermodynamics and Kinetics
    Jinan Wang, Yinglong Miao · 2022 · Journal of Chemical Theory and Computation
57. Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy
    Gustavo Jabor Gozzi, Daniel Gonzalez, Christophe Boudesco, Alexandre M.M. Dias, Guillaume Gotthard, Burhan Uyanik, Lucile Dondaine, Guillaume Marcion, François Hermetet, Camille Denis et al. · 2019 · Cell Death and Differentiation
58. Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products
    M. Wolter, Pim J. de Vink, João Filipe Neves, Sonja Srdanović, Yusuke Higuchi, Nobuo Kato, Andrew John Wilson, Isabelle Landrieu, Luc Brunsveld, Christian Ottmann · 2020 · Journal of the American Chemical Society
59. Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on In silico perspective
    Ibrahim Damilare Boyenle, Ukachi Chiamaka Divine, Rofiat Oluwabusola Adeyemi, Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, Chowdhry Apu, Lei Du, Qian Lü, Xiaoxing Yin, Temitope Isaac Adelusi · 2021 · Pharmacological Research
60. Insights into the development of chemical probes for RNA
    Brittany S. Morgan, Jordan E. Forte, Amanda E. Hargrove · 2018 · Nucleic Acids Research
61. Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
    Greta Bagnolini, Domenico Milano, Marcella Manerba, Fabrizio Schipani, Jose Antonio Ortega, Dario Gioia, Federico Falchi, Andrea Balboni, Fulvia Farabegoli, Francesca Franco et al. · 2020 · Journal of Medicinal Chemistry
62. Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
    Dennis M. Krüger, Adrian Glas, David Bier, Nicole Pospiech, Kerstin Wallraven, Laura Dietrich, Christian Ottmann, Oliver Koch, Sven Hennig, Tom N. Grossmann · 2017 · Journal of Medicinal Chemistry
63. Efficient Classification of Hot Spots and Hub Protein Interfaces by Recursive Feature Elimination and Gradient Boosting
    Xiaoli Lin, Xiaolong Zhang, Xin Xu · 2019 · IEEE Transactions on Computational Biology and Bioinformatics
64. Therapeutic RNA-silencing oligonucleotides in metabolic diseases
    Goga, Algera, Stoffel, Markus · 2022 · Nature Reviews Drug Discovery
65. Recent Advances in Asymmetric Synthesis of Chiral-at-Sulfur Sulfoximines
    Muhammad Suleman, Tianming Huang, Tao Zhou, Zhiyuan Chen, Bing‐Feng Shi · 2025 · ACS Catalysis
66. Rationally Designed Semisynthetic Natural Product Analogues for Stabilization of 14‐3‐3 Protein–Protein Interactions
    Sebastian A. Andrei, Pim J. de Vink, Eline Sijbesma, Ling Han, Luc Brunsveld, Nobuo Kato, Christian Ottmann, Yusuke Higuchi · 2018 · Angewandte Chemie International Edition
67. Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells
    Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, Domenico Milano, Elisa Giacomini, Federico Falchi, Andrea Balboni, Marcella Manerba, Fulvia Farabegoli, Francesca Franco et al. · 2019 · European Journal of Medicinal Chemistry
68. A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
    Sun, Yi, Xu, Lijuan, Zheng, Dongpeng, Wang, Jue, Liu, Guodong, Mo, Zixin, Liu, Chao, Zhang, Wannian, Yu, Jianqiang, Xing, Chengguo et al. · 2023 · Redox Biology
69. A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data
    Péter Buchwald · 2019 · Frontiers in Pharmacology
70. Photoredox Ni-catalyzed peptide C(sp 2 )–O cross-coupling: from intermolecular reactions to side chain-to-tail macrocyclization
    Hyelee Lee, Nicolas C. Boyer, Qiaolin Deng, Hai‐Young Kim, Tomi K. Sawyer, Nunzio Sciammetta · 2019 · Chemical Science
71. GalaxyTongDock: Symmetric and asymmetric ab initio protein–protein docking web server with improved energy parameters
    Taeyong Park, Minkyung Baek, Hasup Lee, Chaok Seok · 2019 · Journal of Computational Chemistry
72. SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases
    Simone Jensen, Jakob Benedict Seidelin, Eric Charles LaCasse, Ole Haagen Nielsen · 2020 · Science Signaling
73. De novo molecular design with deep molecular generative models for PPI inhibitors
    Jianmin Wang, Yanyi Chu, Jiashun Mao, Hyeon-Nae Jeon, Haiyan Jin, Amir Zeb, Yuil Jang, Kwang‐Hwi Cho, Tao Song, Kyoung Tai No · 2022 · Briefings in Bioinformatics
74. Two‐Component Stapling of Biologically Active and Conformationally Constrained Peptides: Past, Present, and Future
    Jessica Iegre, Josephine S. Gaynord, Naomi Robertson, Hannah F. Sore, Marko Hyvönen, David R. Spring · 2018 · Advanced Therapeutics
75. Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale
    Sevan Habeshian, Manuel L. Merz, Gontran Sangouard, Mothukuri Ganesh Kumar, Mischa Schüttel, Zsolt Bognár, Cristina Díaz‐Perlas, Jonathan Vesin, Julien Bortoli Chapalay, Gerardo Turcatti et al. · 2022 · Nature Communications
76. New Approved Drugs Appearing in the Pharmaceutical Market in 2022 Featuring Fragments of Tailor-Made Amino Acids and Fluorine
    Nana Wang, Haibo Mei, Gagan Dhawan, Wei Zhang, Jianlin Han, Vadim A. Soloshonok · 2023 · Molecules
77. Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia
    Lea Albert, Jing Xu, Ruiwei Wan, Vasundara Srinivasan, Yali Dou, Olalla Vázquez · 2017 · Chemical Science
78. Controlling protein function by fine-tuning conformational flexibility
    Sonja Schmid, Thorsten Hugel · 2020 · eLife
79. Streamlining bioactive molecular discovery through integration and automation
    Shiao Y. Chow, Samuel Liver, Adam S. Nelson · 2018 · Nature Reviews Chemistry
80. Structure-based assessment and druggability classification of protein–protein interaction sites
    Lara Alzyoud, Richard A. Bryce, Mohammad Al Sorkhy, Noor Atatreh, Mohammad A. Ghattas · 2022 · Scientific Reports
81. SGPPI: structure-aware prediction of protein–protein interactions in rigorous conditions with graph convolutional network
    Yan Huang, Stefan Wuchty, Yuan Zhou, Ziding Zhang · 2023 · Briefings in Bioinformatics
82. The OncoPPi Portal: an integrative resource to explore and prioritize protein–protein interactions for cancer target discovery
    Andrei A. Ivanov, Brian Revennaugh, Lauren E. Rusnak, Valentina González-Pecchi, Xiulei Mo, Margaret A. Johns, Yuhong Du, Lee Cooper, Carlos S. Moreno, Fadlo Raja Khuri et al. · 2017 · Bioinformatics
83. Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment
    Federica De Leo, Giacomo Quilici, Mario Tirone, Francesco De Marchis, Valeria Mannella, Chiara Zucchelli, Alessandro Preti, Alessandro Gori, Maura Casalgrandi, Rosanna Mezzapelle et al. · 2019 · EMBO Reports
84. Renaissance of Allostery to Disrupt Protein Kinase Interactions
    Alejandro E. Leroux, Ricardo M. Biondi · 2019 · Trends in Biochemical Sciences
85. Preclinical and first-in-human evaluation of 18F-labeled D-peptide antagonist for PD-L1 status imaging with PET
    Ming Zhou, Xiaobo Wang, Bei Chen, Shijun Xiang, Wanqian Rao, Zhe Zhang, Huanhuan Liu, Jianyang Fang, Xiaoqin Yin, Pengbo Deng et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
86. NMR-Fragment Based Virtual Screening: A Brief Overview
    Meenakshi Singh, Benjamin Tam, Barak Akabayov · 2018 · Molecules
87. Graph embedding-based novel protein interaction prediction via higher-order graph convolutional network
    Ze Xiao, Yue Deng · 2020 · PLoS ONE
88. Mining Natural Products for Macrocycles to Drug Difficult Targets
    Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, Marie Castaldo, Stefan Geschwindner, Patrik Johansson, Mohit Tyagi, Christian Tyrchan, Lisa Wissler, Peter Sjö et al. · 2020 · Journal of Medicinal Chemistry
89. Progress in the therapeutic inhibition of Cdc42 signalling
    Natasha P. Murphy, Helen R. Mott, Darerca Owen · 2021 · Biochemical Society Transactions
90. Tailored Biosensors for Drug Screening, Efficacy Assessment, and Toxicity Evaluation
    Yi Tao, Lin Chen, Meiling Pan, Fei Zhu, Dong Zhu · 2021 · ACS Sensors
91. Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
    Chao Wang, Yujing Zhang, Lingyu Shi, Shanbo Yang, Jing Chang, Yingjie Zhong, Qian Li, Dongming Xing · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
92. Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics
    Georgina Alexandra Cardama, Daniel F. Alonso, Nazareno González, Julián Maggio, Daniel Eduardo Gomez, Christian Diego Rolfo, Pablo Lorenzano Menna · 2018 · Critical Reviews in Oncology/Hematology
93. An Update on MDMX and Dual MDM2/X Inhibitors
    Margarida Espadinha, Valentina Barcherini, Elizabeth A. Lopes, Maria M. M. Santos · 2018 · Current Topics in Medicinal Chemistry
94. Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification
    Lin Xu, Jiaqi Zhang, Yifan Wang, Zedan Zhang, Fengyun Wang, Xudong Tang · 2021 · Bioscience Reports
95. Molecular glues to stabilise protein–protein interactions
    Lorenzo Soini, S. Leysen, Jeremy Davis, Christian Ottmann · 2022 · Current Opinion in Chemical Biology
96. Constrained Peptides in Drug Discovery and Development
    Douglas R. Cary, Masaki Ohuchi, Patrick Reid, Keiichi Masuya · 2017 · Journal of Synthetic Organic Chemistry Japan
97. Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments
    Stéphanie M. Guéret, Sasikala Thavam, Rodrigo J. Carbajo, Marco Potowski, Niklas Larsson, Göran Dahl, Anita Dellsèn, Tom N. Grossmann, Alleyn T. Plowright, Eric Valeur et al. · 2020 · Journal of the American Chemical Society
98. Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions
    Nicolas Bosc, Christophe Müller, Laurent Hoffer, David Lagorce, Stéphane Bourg, Carine Derviaux, Marie‐Edith Gourdel‐Martin, Jean‐Christophe Rain, Thomas W. Miller, Bruno O. Villoutreix et al. · 2020 · ACS Chemical Biology
99. RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma
    Jonas Pyko, Julia Rosemann, Vanessa Krauspe, Matthias Kappler, Alexander W. Eckert, Monika Hämmerle, Tony Gutschner · 2020 · International Journal of Molecular Sciences
100. Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
     Rink‐Jan Lohman, Johan Kamal Hamidon, Robert C. Reid, Jessica A. Rowley, Mei‐Kwan Yau, Maria A. Halili, Daniel S. Nielsen, Junxian Lim, Kai‐Chen Wu, Zhixuan Loh et al. · 2017 · Nature Communications